A detailed history of Fmr LLC transactions in Generation Bio Co. stock. As of the latest transaction made, Fmr LLC holds 5,304,610 shares of GBIO stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,304,610
Previous 5,334,259 0.56%
Holding current value
$12 Million
Previous $21.7 Million 31.1%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.64 - $4.35 $78,273 - $128,973
-29,649 Reduced 0.56%
5,304,610 $15 Million
Q1 2024

May 13, 2024

SELL
$1.73 - $4.07 $31,382 - $73,829
-18,140 Reduced 0.34%
5,334,259 $21.7 Million
Q4 2023

Feb 13, 2024

SELL
$0.91 - $3.35 $2.8 Million - $10.3 Million
-3,080,374 Reduced 36.53%
5,352,399 $8.83 Million
Q3 2023

Nov 13, 2023

SELL
$3.65 - $6.9 $692,748 - $1.31 Million
-189,794 Reduced 2.2%
8,432,773 $32 Million
Q2 2023

Aug 11, 2023

SELL
$3.5 - $5.67 $1.15 Million - $1.86 Million
-327,296 Reduced 3.66%
8,622,567 $47.4 Million
Q1 2023

May 11, 2023

BUY
$3.61 - $7.01 $131,880 - $256,089
36,532 Added 0.41%
8,949,863 $38.5 Million
Q4 2022

Feb 13, 2023

BUY
$3.66 - $6.77 $225,631 - $417,356
61,648 Added 0.7%
8,913,331 $35 Million
Q3 2022

Nov 10, 2022

BUY
$4.68 - $8.34 $1.35 Million - $2.41 Million
288,742 Added 3.37%
8,851,683 $47 Million
Q2 2022

Aug 12, 2022

BUY
$4.87 - $9.41 $59,287 - $114,557
12,174 Added 0.14%
8,562,941 $56.2 Million
Q1 2022

May 13, 2022

BUY
$4.16 - $7.76 $59,508 - $111,006
14,305 Added 0.17%
8,550,767 $62.8 Million
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $116,056 - $483,793
19,375 Added 0.23%
8,536,462 $60.4 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $441,300 - $605,242
22,065 Added 0.26%
8,517,087 $214 Million
Q2 2021

Aug 13, 2021

BUY
$24.34 - $38.34 $207 Million - $326 Million
8,495,022 New
8,495,022 $229 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $133M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.